Sanofi India Q3'26 Results: Net Profit Surges 54% YoY; ₹75 Interim Dividend Declared
Sanofi India Ltd · Outcome · 30 Oct 2026, 12:02 am
Sanofi India Q3'26 Results: Net Profit Surges 54% YoY; ₹75 Interim Dividend Declared Sanofi India reported a 3.4% YoY rise in Q3'26 revenue from operations to ₹4,917 million, driven by 9% growth in its diabetes injectable portfolio, which holds a 55% market share. Net profit jumped 53.6% YoY to ₹1,167 million, supported by an 8% reduction in operating expenses and provision reversals. Profit before tax margin expanded to 34% from 29% in Q3'25. Additionally, the Board declared an interim dividend of ₹75 per equity share (face value ₹10), fixing the record date as 5th Nov'26.
Original exchange filing (PDF)
More announcements from Sanofi India Ltd
- Kindly refer the attachment · 18 Nov 2026
- Kindly refer the attachment · 30 Oct 2026
- Kindly refer the attachment · 30 Oct 2026
- Kindly refer the attachment · 30 Oct 2026
- Kindly refer the attachment · 30 Oct 2026
- Kindly refer the attachment · 30 Oct 2026
- Sanofi India Limited has submitted to the Exchange, the unaudited financial results for the quarter and nine months ended 30th September 2026. · 29 Oct 2026
- Kindly refer the attachment · 29 Oct 2026
